Per adhoc wurde am 08.12.25 bekannt, dass CEO Maximilian Foerst seine am 01.06.25 begonnene Vorstandstätigkeit am 31.12.25 (einvernehmlich) beenden werde. Grund: „ein Verstoß gegen den internen Verhaltenskodex der Zeiss-Gruppe, der im Zusammenhang mit einem Interessenskonflikt im Umgang mit einer Person im Zeiss-internen Arbeitsumfeld stehe“. Foersts Regelverstoß liegt den Angaben zufolge einige Jahre zurück. Der Fall stehe nicht im Zusammenhang mit den geschäftlichen Aktivitäten der Zeiss-Grupp...
On 8 December 2025, it was announced via ad hoc that CEO Maximilian Foerst would be stepping down from his position on the Executive Board, which he had taken up on 1 June 2025, on 31 December 2025 (by mutual agreement). The reason: ‘a violation of the Zeiss Group's internal code of conduct in connection with a conflict of interest in dealing with a person in Zeiss's internal working environment’. According to the information provided, Foerst's violation of the rules occurred several years ago. ...
While the DAX year-to-date has clearly outperformed most of the large European and US indexes (except the IBEX), many corporates presenting at the 16th edition of our Corporate Conference, hosted jointly by ODDO BHF and Commerzbank, were still focused on the macroeconomic environment, geopolitical tensions and tariffs and the related impact on their sectors. Unsurprisingly, the clearly most positive sector was defence. For others, the picture was more mixed inside the sectors. Based on the feedb...
ODDO BHF and Commerzbank are jointly hosting the 16th edition of the Corporate Conference on 3 and 4 of September 2025 in Frankfurt am Main. This year, we are welcoming 88 German small, mid and large cap companies. Among the companies which presented during the first day, we highlight, notably, positive feedback from Adesso, BASF, Befesa, Commerzbank, Fresenius Medical Care, Fresenius SE, Fuchs, Hannover RE, Hensoldt, Implenia, Sartorius, Schott Pharma, Tonies and Zalando ADESSO (+) - Positive ...
Q3/25 wurde durch negative FX-Effekte und US-Zölle gedämpft (YoY in CC: Q3-Umsatz/ Q3-EBITA: +3,5 %/ +9 %), die Vollkonsolidierung DORC unterstützte das Volumenwachstum - die adj. Marge stieg YoY um 50 BP auf 7,7 %. Die Orderdynamik, und damit die Produktionsreichweite, nahm jüngst zu. Das 9M/25-adj. EPS erreichte € 1,24 (9M/24: € 1,35).
Q3/25 was dampened by negative FX effects and US tariffs (YoY in CC: Q3 revenue/Q3 EBITA: +3.5%/+9%), the full consolidation of DORC supported volume growth - the adjusted margin increased by 50 BP YoY to 7.7%. Order dynamics, and thus production capacity, have recently increased. The 9M/25 adjusted EPS reached €1.24 (9M/24: €1.35).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.